| OALBX0107 | Long acting cabotegravir: updated efficacy and safety results from HPTN 084 | Oral abstract session with live Q&A | Other new HIV prevention tools |
| OALBX0106 | Trends in PrEP inequity by race and census region, United States, 2012-2021 | Oral abstract session with live Q&A | Scale up of PrEP |
| OALBX0105 | Week 48 results of a Phase 3 randomized controlled trial of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) vs dolutegravir + emtricitabine/tenofovir Disoproxil Fumarate (DTG+F/TDF) as initial treatment in HIV/HBV-coinfected adults (ALLIANCE) | Oral abstract session with live Q&A | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| OALBX0103 | Doxycycline post-exposure prophylaxis for STI prevention among MSM and transgender women on HIV PrEP or living with HIV: high efficacy to reduce incident STI's in a randomized trial | Oral abstract session with live Q&A | STIs (including HPV) |
| OALBX0102 | Transcriptional programs of HIV silencing and cell survival in HIV-infected memory CD4 T cells under antiretroviral therapy | Oral abstract session with live Q&A | Host cellular factors and viral mechanisms of HIV/SIV persistence and latency |
| OALBF0105 | Strengthening TB/HIV human rights programming to overcome barriers to accessing TB services | Oral abstract session with live Q&A | Human rights programmes |
| OALBF0104 | Education as an enabling factor to HIV prevention and adherence to treatment | Oral abstract session with live Q&A | Access to education |
| OALBF0103 | Preliminary report on the provision of HIV care to war refugees living with HIV who are migrating from Ukraine - data from ECEE Network Group | Oral abstract session with live Q&A | Humanitarian crises |
| OALBF0102 | Canada's criminal injustice: new national community consensus on law reform to end HIV criminalization | Oral abstract session with live Q&A | Laws and policies on HIV transmission, exposure, and non-disclosure |
| OALBE0105 | The catalytic role of dual HIV/syphilis rapid diagnostic tests in accelerating national elimination of mother-to-child-transmission in Nigeria | Oral abstract session with live Q&A | Getting policies into practice |